LaBrosse Nicole's Form 4 filing
Halozyme Therapeutics, Inc. (HALO) · filed Jun 28, 2024
- Accession no.
- 0001415889-24-018408
- Filed
- Jun 28, 2024
- Trade date
- Jun 26-28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.56M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LaBrosse NicoleCIK 0001910662 | Officer (SVP, CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $22.50 | +$225,000 | 25,480 | Direct | |
| Jun 26, 2024 | Common Stock | SSaleDisposed | −10,000 | $51.82 | −$518,200 | 15,480 | Direct | |
| Jun 27, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $22.50 | +$225,000 | 25,480 | Direct | |
| Jun 27, 2024 | Common Stock | SSaleDisposed | −10,000 | $51.93 | −$519,300 | 15,480 | Direct | |
| Jun 28, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $22.50 | +$225,000 | 25,480 | Direct | |
| Jun 28, 2024 | Common Stock | SSaleDisposed | −10,000 | $52.04 | −$520,400 | 15,480 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 25,000 | Direct | |
| Jun 27, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 15,000 | Direct | |
| Jun 28, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 5,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.